GRAIL's Series B - IV Round

GRAIL raised a round of funding on January 11, 2018.

GRAIL is a life sciences company with a mission to detect cancer early when it can be cured. GRAIL combines the power of high-intensity sequencing (ultra-broad and ultra-deep sequencing), leading-edge…

Articles about GRAIL's Series B - IV Round: